North Run Capital’s Stereotaxis STXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$668K Buy
322,750
+71,590
+29% +$140K 1.53% 19
2022
Q3
$452K Buy
251,160
+56,510
+29% +$121K 0.92% 23
2022
Q2
$358K Buy
+194,650
New +$465K 0.73% 22

Other funds holding STXS

North Run Capital's STXS Position: Q4 2022 in Review

North Run Capital increased its Stereotaxis (STXS) stake by 29% in Q4 2022, buying an estimated $140K and bringing the position to 322,750 shares worth $668K. The position accounts for 1.53% of the portfolio, ranked #19.

North Run Capital first reported a position in STXS in Q2 2022 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold STXS as of Q4 2022.

  • North Run Capital held 322,750 shares of Stereotaxis worth $668K as of Q4 2022.
  • North Run Capital bought 71,590 Stereotaxis shares in Q4 2022, an estimated $140K.
  • Stereotaxis made up 1.53% of North Run Capital's portfolio in Q4 2022, its #19 holding.
  • North Run Capital first reported a position in Stereotaxis in Q2 2022 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Stereotaxis as of Q4 2022.

Based on North Run Capital's 13F filing for Q4 2022, filed 14 Feb 2023.